Recently, within a cohort of 205 LGLL patients, we studied 23 Tγδ LGLL and demonstrated that the Tγδ variant of the disease shares biological and clinical features with the Tαβ disease subgroup16. The gene discussed is ABCA1; the disease is T-cell large granular lymphocyte leukemia.